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Summary
Coordination between cell proliferation and cell death
is essential to maintain homeostasis in multicellular
organisms. In Drosophila, these two processes are
regulated by a pathway involving the Ste20-like ki-
nase Hippo (Hpo) and the NDR family kinase Warts
(Wts; also called Lats). Hpo phosphorylates and acti-
vates Wts, which in turn, through unknown mecha-
nisms, negatively regulates the transcription of cell-
cycle and cell-death regulators such as cycE and
diap1. Here we identify Yorkie (Yki), the Drosophila
ortholog of the mammalian transcriptional coactiva-
tor yes-associated protein (YAP), as a missing link
between Wts and transcriptional regulation. Yki is re-
quired for normal tissue growth and diap1 transcrip-
tion and is phosphorylated and inactivated by Wts.
Overexpression of yki phenocopies loss-of-function
mutations of hpo or wts, including elevated transcrip-
tion of cycE and diap1, increased proliferation, de-
fective apoptosis, and tissue overgrowth. Thus, Yki is
a critical target of the Wts/Lats protein kinase and a
potential oncogene.
Introduction
The increase in cell number that accompanies the
growth of an organ or organism results from the bal-
anced coordination of three simultaneous processes,
including cell growth, cell proliferation, and cell death
(reviewed by Conlon and Raff, 1999; Hipfner and Co-
hen, 2004). Cell growth is a prerequisite for cell prolifer-
ation during normal organ growth, and sustained cell
proliferation must be coupled to appropriate cell growth.
With appropriate cell growth, a net increase in cell num-
ber in a growing organ depends on the rate at which
they are generated via cell proliferation, as well as the
rate at which they are eliminated by cell death (apopto-
sis). How cell proliferation and cell death are coordinated
during tissue growth and homeostasis is yet to be com-
pletely understood, and this mechanism must be intact
throughout life to prevent diseases such as cancer.
Recent studies in mice and fruit flies have revealed
two distinct modes in which cell proliferation and cell
death could be coupled. In the first mode, increased*Correspondence: djpan@jhmi.edu
2 Present address: Department of Molecular Biology and Genetics,
Johns Hopkins University School of Medicine, Baltimore, Mary-
land 21205.proliferation, such as that resulting from activation of
the Myc oncogene, is coupled in an obligatory fashion
to increased cell death. Such coupling between prolif-
eration and apoptosis provides an important failsafe
mechanism to prevent inappropriate proliferation of so-
matic cells (Lowe et al., 2004). In the second mode,
increased proliferation, such as that resulting from acti-
vation of the microRNA bantam, or inactivation of the
tumor suppressors hippo (hpo), salvador (sav), and
warts (wts), is accompanied by an inhibition of cell
death (reviewed by Hipfner and Cohen, 2004; Hay and
Guo, 2003; Ryoo and Steller, 2003). Here, suppression
of cell death might allow the overproliferating cells to
overcome proliferation-induced apoptosis, thus result-
ing in a robust increase in organ size. In many aspects,
these circumstances resemble certain cancer cells,
which display both increased cell proliferation and sup-
pressed cell death (Lowe et al., 2004).
hpo, sav, and wts (also called lats) were identified
from genetic screens in Drosophila for negative regula-
tors of tissue growth (Xu et al., 1995; Justice et al.,
1995; Tapon et al., 2002; Kango-Singh et al., 2002; Har-
vey et al., 2003; Wu et al., 2003; Jia et al., 2003; Udan
et al., 2003; Pantalacci et al., 2003). Inactivation of any
of these genes results in increased cell proliferation and
reduced apoptosis. hpo encodes a Ste20 family protein
kinase, sav encodes a protein containing WW and
coiled-coil domains, and wts encodes an NDR (nuclear
Dbf-2-related) family protein kinase. Studies from sev-
eral groups, including our own, have suggested that
these genes function in a common pathway that coor-
dinately regulates cell proliferation and apoptosis by
targeting the cell-cycle regulator CycE and the cell-
death inhibitor DIAP1 (Tapon et al., 2002; Kango-Singh
et al., 2002; Harvey et al., 2003; Wu et al., 2003; Jia et
al., 2003; Udan et al., 2003; Pantalacci et al., 2003).
Using a combination of genetic and biochemical as-
says, we previously showed that Hpo, Sav, and Wts de-
fine a novel protein kinase cascade wherein Hpo, facili-
tated by Sav, phosphorylates Wts (Wu et al., 2003). We
further demonstrated that this pathway, hereafter re-
ferred to as the Hpo pathway, negatively regulates the
transcription of diap1 (Wu et al., 2003). It is worth noting
that our model differs significantly from an alternative
model by others that suggests that this pathway regu-
lates DIAP1 posttranscriptionally through phosphoryla-
tion of DIAP1 by Hpo (Tapon et al., 2002; Harvey et al.,
2003; Pantalacci et al., 2003). Another unresolved issue
in Hpo signaling concerns the molecular mechanism of
the Wts/Lats kinase. While previous studies have iden-
tified a number of putative targets for this tumor sup-
pressor, including the G2/M regulator cdc2 (Tao et al.,
1999) and the actin regulators zyxin (Hirota et al., 2000)
and LIMK1 (Yang et al., 2004), none of them could ac-
count for the excessive overgrowth associated with wts
mutant clones. Thus, the most critical target of the Wts/
Lats kinase has remained elusive.
Here we identify yorkie (yki) as the elusive target of
the Wts/Lats tumor suppressor. yki encodes the Dro-
sophila ortholog of yes-associated protein (YAP), a
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422transcriptional coactivator in mammalian cells (Yagi et (
dal., 1999; Strano et al., 2001; Vassilev et al., 2001). Yki
is required for normal tissue growth and diap1 tran- f
mscription and is phosphorylated and inactivated by
Wts. Overexpression of yki phenocopies loss-of-func- i
Ltion mutations of hpo, sav, or wts. Taken together, our
studies identify a missing link between Hpo signaling d
iand transcriptional control and provide further support
for our model implicating the Hpo signaling pathway in o
transcriptional regulation of diap1. Our studies further
reveal a functional conservation between YAP and Yki A
and implicate YAP as a potential oncogene in mammals. O
P
TResults
“
yIdentification of Yki as a Wts Binding Protein
ZOur previous studies of the Hpo signaling pathway
oplaced Wts as the most downstream component
Wamong Hpo, Sav and Wts. In an effort to extend this
ppathway further downstream, we carried out a yeast
otwo-hybrid screen for Wts binding proteins. Using the
(noncatalytic N-terminal portion of Wts (1–608) as bait
cand from 1 million cDNA clones, we isolated three inde-
upendent clones representing partial sequences of a
ngene annotated as CG4005 by the Berkeley Drosophila
dGenome Project (Figure 1A). We named this gene yorkie
t(yki) after Yorkshire Terriers, one of the world’s smallest
vbreeds of pet dogs, according to its loss-of-function
Bphenotype (see later in Figure 4C). Consistent with the
cyeast two-hybrid results, Wts and Yki coimmunoprecip-
sitate with each other in Drosophila S2 cells (Figure 1B).
aYki is most closely related to the human yes-associ-
gated protein (YAP, also called YAP65) (Sudol, 1994), with
31% identity between the two proteins (Figure 1C).
oBoth proteins contain two WW domains, protein-pro-
ltein interaction modules of 35–40 amino acids that are
iknown to interact with PPXY-containing polypeptides
f(Macias et al., 2002). The similarity between Yki and
cYAP extends beyond the WW domains and includes a
Tstretch of sequence similarity at the N-terminal part of
pthe proteins (Figure 1C). While initially isolated as a pro-
ctein that interacts with the SH3 domain of the Yes
fproto-oncogene, the involvement of YAP in Yes signal-
ting has not been validated (Sudol, 1994). Notably, the
scorresponding SH3 binding region (Sudol, 1994) is ab-
isent in the Drosophila Yki protein (Figure 1C). On the
pother hand, YAP has been implicated as a transcrip-
ftional coactivator, a class of transcriptional regulators
sthat do not bind to DNA themselves but associate with
cDNA binding transcription factors and supply or stimu-
tlate transcriptional activation of the cognate transcrip-
otion factors. Specifically, YAP has been shown to func-
etion as a coactivator for a number of transcription
pfactors, such as the p53 family transcription factor p73
(Strano et al., 2001), the Runt family protein PEBP2α
(Yagi et al., 1999), and the TEAD/TEF family transcrip- A
Ition factors (Vassilev et al., 2001). However, these
studies have been performed exclusively in cultured A
Fmammalian cells and little is known about the physio-
logical function of YAP. n
fThe three independent Wts-interacting clones isolated
from the yeast two-hybrid screen define the C-terminal h
thalf of Yki (residues 229–418) as a Wts binding regionFigure 1C). This region contains the two predicted WW
omains, suggesting that the WW domains are required
or Yki-Wts binding. Consistent with this hypothesis,
utating two critical residues of the WW domains abol-
shed the binding between Yki and Wts (Figure 1B).
ikewise, the N-terminal half of the Yki protein, which
oes not contain the WW domains, did not bind to Wts
n the same assay (Figure 1B). Thus, the WW domains
f Yki are required for its interaction with Wts.
ctivation of yki Leads to Massive Tissue
vergrowth that Resembles the Loss-of-Function
henotype of hpo, sav, or wts
o probe the physiological function of yki, we used the
flip-out” technique to generate clones of cells in which
ki is overexpressed during development (Pignoni and
ipursky, 1997). yki-overexpressing clones led to marked
vergrowth in adult epithelial structures (Figure 2A).
ing imaginal discs containing multiple yki-overex-
ressing clones could reach up to eight times the area
f control wing discs raised under identical conditions
Figure 2C). Besides the overgrowth phenotype, adult
uticles secreted by yki-overexpressing cells display an
nusual texture. In yki-overexpressing clones on the
otum, the apical surface of the epidermal cells is
omed such that cell-cell boundaries are visible be-
ween adjacent cells, whereas cell boundaries are not
isible in the neighboring wild-type tissues (Figure 2B).
oth the overgrowth and the abnormal cell morphology
aused by yki overexpression closely resemble those
hown previously for hpo and wts mutant cells (Wu et
l., 2003; Justice et al., 1995), suggesting that these
enes might function in a common pathway.
We measured cell-doubling time for control and yki-
verexpressing cells in the wing imaginal disc by ana-
yzing well-separated flip-out clones 48 hr post clone
nduction (Figures 2D and 2E). The cell-doubling time
or wild-type and yki-overexpressing clones (30 pairs of
lones analyzed) was 16.1 hr and 12.0 hr, respectively.
hus, like mutant clones of hpo or wts, yki-overex-
ressing cells multiply faster. Notably, while cells in the
ontrol clones intermingle with their neighbors and
orm wiggly borders, yki-overexpressing cells minimize
heir contacts with their neighbors and form round
mooth borders (Figures 2D and 2E). This phenotype
ndicates distinct adhesive properties of the yki-overex-
ressing cells and resembles that seen with loss-of-
unction wts clones (Figures 2F and 2G). FACS analysis
howed that yki-overexpressing cells have a similar
ell-cycle profile and cell size distribution as compared
o wild-type cells (Figure 2H). Thus, like loss-of-function
f hpo (Wu et al., 2003), activation of yki does not accel-
rate a particular phase of the cell cycle. Rather, each
hase of the cell cycle is proportionally accelerated.
ctivation of yki in the Eye Imaginal Disc Leads to
ncreased Number of Interommatidial Cells without
ffecting Photoreceptor Differentiation
or the rest of the study, we focused on the eye imagi-
al disc, a pseudostratified epithelium in which cell dif-
erentiation, proliferation, and apoptosis occur in a
ighly stereotyped manner (Wolff and Ready, 1993). In
he third instar, the morphogenetic furrow (MF) tra-
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(A) Isolation of Yki as a Wts binding protein by yeast two-hybrid. The cdc25H strain was transformed with the indicated plasmids and plated
at permissive (25°C) and restrictive (37°C) temperature in galactose (prey expression induced) or glucose (prey expression suppressed)
medium. Sos-Wts is the bait for library screening. Sos is empty bait containing Sos only. Myr is empty prey containing the myristylation signal
only. 18–418, 186–418, 229–418 are three independent Yki clones isolated from the screen with the numbers representing the starting and
ending positions of the Yki polypeptides in the clones.
(B) Physical association between Yki and Wts. HA-tagged wild-type Yki (Yki, lane 1), a mutant Yki carrying point mutations in the WW domains
(YkiW292A P295A W361A P364A, abbreviated as YkiWM in lane 2), or a truncated Yki containing only the N-terminal half of the protein (YkiN, lane 3)
were coexpressed with V5-tagged Wts. α-HA immunoprecipitates were probed with α-V5.
(C) Alignment of Yki (418 aa) with the human YAP protein (504 aa). The starting position of the three Yki clones identified in the yeast two-
hybrid screen is indicated by arrows. WW domains are indicated by single underlines. The Pro-rich motif of YAP that binds to the SH3 domain
of Yes is indicated by double underlines. The alanine mutations that were used to mutate the WW domains in YkiWM are also indicated.verses the eye disc from posterior to anterior. Cells an-
terior to the MF are undifferentiated and divide asyn-
chronously, whereas cells in the MF are synchronized
in the G1 phase of the cell cycle. Posterior to the MF,
cells either exit the cell cycle and differentiate or un-
dergo one round of synchronous division (second mi-
totic wave, SMW) before differentiation. These cellsassemble into approximately 750 ommatidia, leaving
behind approximately 2000 superfluous cells that are
eliminated by a wave of apoptosis w36 hr after pupar-
ium formation (APF).
To investigate whether activation of yki perturbs pho-
toreceptor differentiation, we examined the neuronal
marker Elav. As seen in Figures 2I–2I$, yki-overexpress-
Cell
424Figure 2. Overexpression of yki Drives Overgrowth
(A) Scanning electron micrograph of Drosophila notum showing a large overgrowth (arrow) caused by a yki-overexpressing clone.
(B) A high-magnification view of epidermal cells near the border of a yki-overexpressing clone on the notum. The dashed line marks the
border between the wild-type cells and the mutant clone. The mutant clone is located to the left of the border. Note the honeycomb-like
appearance of the yki-overexpressing cells, which was not seen in the neighboring wild-type epidermal cells.
(C) yki-overexpressing clones result in massive overgrowth of third instar wing discs. The inset at the lower left corner shows a sibling control
wing disc without yki overexpression.
(D and E) Wing imaginal discs containing 48-hr-old control (D) and yki-overexpressing clones (E) generated by flip-out and positively marked
by GFP. Note the difference in the sizes and shapes of the clones.
(F and G) Wing imaginal discs containing 48-hr-old control and wts mutant clones generated by FLP/FRT and marked by the absence of GFP.
Note the difference in the sizes and shapes of the clones.
(H) Flow cytometric analysis. The DNA profiles of control and yki-overexpressing cells are indicated by red and green traces, respectively.
The inset shows forward scattering (FSC), which measures cell size.
(I–I$) Third instar eye disc containing a yki-overexpressing clone (marked positively by GFP) and stained for the neuronal-specific Elav
protein (red). Single-channel and composite images are shown as indicated. Note the presence of Elav-positive photoreceptor clusters in yki-
overexpressing clone (indicated by arrows), as well as increased spacing between photoreceptor clusters in the clone. Arrowhead marks
the MF.
(J–J$) Forty hour pupal eye containing a yki-overexpressing clone (marked positively by GFP) and stained for phalloidin (red), which highlights
the outlines of the cells, and Armadillo (blue), which at this focal plane labels the apical cell surface of photoreceptors. Note the presence of
a normal complement of photoreceptors and supernumerary interommatidial cells in the yki-overexpressing clone (indicated by arrows), as
well as the increased spacing between photoreceptor clusters.ing ommatidial clusters have the normal complement m
pof photoreceptor cells. The spacing between adjacent
ommatidial clusters is increased due to the presence t
tof extra interommatidial cells (Figures 2I–2I$). The for-ation of extra interommatidial cells is most evident in
upal eye discs, when yki-overexpressing clones con-
ain many additional cells between photoreceptor clus-
ers (Figures 2J–2J$). Thus, like loss-of-function of hpo,
Yki, Target of the Wts/Lats Tumor Suppressor
425sav, or wts, yki overexpression results in an increased
number of uncommitted, interommatidial cells without
affecting early retina patterning.
Activation of yki Leads to Increased Cell
Proliferation and Decreased Apoptosis
To pinpoint the developmental cause of yki-induced
overgrowth, we monitored cell proliferation and apo-
ptosis in eye imaginal discs. In wild-type eye discs (Fig-
ures 3A), cells posterior to the MF undergo a synchro-
nous second mitotic wave (SMW) that can be revealed
as a band of BrdU-positive cells. Few BrdU-positive
cells are found posterior to the SMW. In yki-overex-
pressing clones, cells fail to undergo cell-cycle arrest
posterior to the SMW and continue cell cycles as
shown by BrdU incorporation (Figures 3B–3B$) as well
as M phase marker phospho-histone H3 (PH3) (data not
shown). Thus, yki overexpression results in increased
cell proliferation.
Using the TUNEL assay, we monitored cell death in
the pupal retina when a wave of apoptosis normally re-Figure 3. Overexpression of yki Promotes
Cell Proliferation and Inhibits Apoptosis
In all panels, yki-overexpression clones were
generated using the Act>CD2>Gal4 flip-out
in conjunction with UAS-GFP and UAS-yki
transgene and were positively marked by
GFP (arrows). Single-channel and composite
images are shown as indicated.
(A) Wild-type third instar eye disc labeled by
BrdU incorporation (red). Note the synchro-
nized band of S phase cells in the SMW (ar-
rowhead).
(B–B$) Third instar eye disc containing yki-
overexpressing clones and labeled with
BrdU. Note the continued BrdU incorpora-
tion posterior to SMW in yki-overexpressing
clones. Arrowhead marks the SMW.
(C–C$) Thirty-six hour APF pupal eye con-
taining yki-overexpressing clones and la-
beled with TUNEL. Cell death is absent in
yki-overexpressing clones but abundant in
the neighboring wild-type cells.
(D–D$) Third instar eye disc containing yki-over-
expressing clones and stained with α-DIAP1
antibody. Note the cell-autonomous increase in
DIAP1 protein levels in yki-overexpressing
cells.
(E−E$) yki-overexpressing clones were gen-
erated in flies containing the diap1-lacZ re-
porter thj5c8 and stained for lacZ protein.
Note the cell-autonomous increase in diap1-
lacZ expression in yki-overexpressing cells.
(F–F$) yki-overexpressing clones were gen-
erated in flies containing a cycE-lacZ repor-
ter and stained for lacZ protein. Arrowhead
marks the MF. Note a modest increase in
cycE-lacZ expression in yki-overexpressing
cells.moves excess interommatidial cells around 36 hr APF.
Strikingly, cell death was significantly suppressed in
yki-overexpressing clones, even though abundant apo-
ptosis was detected in the neighboring wild-type cells
(Figures 3C–3C$). Thus, normal developmental cell
death is largely inhibited by yki overexpression.
Activation of yki Leads to Increased Transcription
of diap1 and CycE
The increased cell proliferation and decreased apopto-
sis resulting from yki overexpression are strikingly sim-
ilar to those caused by loss of hpo, sav, or wts, sug-
gesting that Yki functions in the Hpo pathway. To
further explore this possibility, we examined the tran-
scription of cell-death inhibitor diap1 and cell-cycle
regulator cycE, known targets of the Hpo pathway (Wu
et al., 2003). Elevated DIAP1 protein was detected in
yki-overexpressing clones in the eye discs (Figures 3D–
3D$). This regulation is largely mediated at the level of
diap1 transcription since the expression of thj5c8, a
P[lacZ] enhancer trap reporter inserted into the diap1
Cell
426locus, was similarly elevated in yki-overexpressing T
Iclones in a cell-autonomous manner (Figures 3E–3E$).
TA cycE-lacZ reporter containing 16.4 kb of the 5# regu-
mlatory sequence of cycE (Jones et al., 2000) was also
aincreased in yki-overexpressing clones, especially those
nclose to the MF (Figures 3F–3F$), although the effect
owas less profound than that observed with the diap1
ureporter. Thus, like loss of hpo, sav, or wts, overexpres-
Ysion of yki results in increased transcription of diap1
tand cycE. It is worth noting that our previous analyses
aof hpo mutant clones also revealed a “tighter” regula-
dtion of diap1: while diap1 transcription is elevated in all
shpo mutant cells irrespective of their relative position
uto the MF, cycE transcription is only elevated in hpo
mutant cells close to the MF (Wu et al., 2003). These
Yobservations suggest that diap1 might represent a
emore direct transcriptional target of the Hpo pathway.
s
t
fyki Is Required for Tissue Growth
Gand Normal diap1 Transcription
fTo further explore the role of Yki in Hpo signaling, we
rgenerated a loss-of-function mutation of yki by homolo-
ogous recombination (Gong and Golic, 2003). Our tar-
cgeting construct was designed in such a way that all of
tthe coding sequence of yki was replaced by the w+
smarker, thus resulting in a null allele (Figure 4A). yki null
i
mutants are homozygous lethal and die as late em-
p
bryos and early first instar larvae. A full-length yki cDNA
a
driven by the ubiquitous α-tubulin promoter completely
d
rescued yki null animals to viable and phenotypically S
normal adult flies. t
We used eyeless-FLP to selectively remove yki func- a
tion in over 90% of the eye disc cells (Newsome et al.,
2000). Eyes composed predominantly of yki mutant
cells were markedly reduced in size when compared D
to control animals (Figures 4B–4B# and 4C–4C#), thus b
revealing an essential function for yki in tissue growth. T
To follow yki mutant cells during development, we used H
FLP/FRT to examine genetically marked clones of yki t
mutant cells. yki mutant clones generated at 40 hr AED o
were hardly observed in third instar wing discs, with i
rare clones recovered containing only a few cells (Fig- t
ures 4D–D$). yki mutant clones generated at a similar t
stage were more frequently recovered in the eye discs p
but contained much fewer cells than the wild-type twin c
spots (Figure 4F). Despite the severe growth defects, G
loss of yki did not perturb early retina differentiation, as i
shown by the normal expression of the neuronal marker h
Elav (Figure 4E). Taken together, these results reveal a m
specific requirement for yki in tissue growth. i
To further probe the requirement of Yki in the Hpo b
pathway, we examined diap1 transcription in yki mutant l
clones using the thj5c8 diap1-lacZ reporter. Consistent (
with the overexpression results (Figure 3), diap1-lacZ t
expression was reduced in yki null cells in a cell-auton- m
omous manner (Figure 4F). Similar results were seen in W
the wing discs (data not shown). DIAP1 protein level h
was also reduced in a cell-autonomous manner in yki c
mutant clones (see later, Figures 7A–7A$). Thus, yki is t
required for the normal level of diap1 transcription in t
gDrosophila.he Transcriptional Coactivator Activity of Yki
s Negatively Regulated by the Hpo Pathway
he results presented so far are consistent with a
odel wherein Yki acts antagonistically to Hpo, Sav,
nd Wts in a common signaling pathway that coordi-
ately controls cell proliferation and apoptosis. Based
n the physical interactions between Yki and Wts (Fig-
re 1), and given that YAP, the mammalian homolog of
ki, is known to function as a transcriptional coactiva-
or (Yagi et al., 1999; Strano et al., 2001; Vassilev et
l., 2001), we further hypothesized that Yki functions
ownstream of Wts to regulate transcription of genes
uch as diap1 and that the Hpo pathway negatively reg-
lates the coactivator activity of Yki.
To test our hypothesis that the coactivator activity of
ki is negatively regulated by the Hpo pathway, we first
stablished a transcription assay for Yki activity in Dro-
ophila S2 cells. Since the cognate transcription fac-
or(s) that partner with Yki are not yet identified, we
used Yki to the DNA binding domain (DB) of the yeast
al4 transcription factor (Figure 5A). The activity of this
usion construct was then assayed using a Gal4-
esponsive reporter. Consistent with previous reports
f YAP as a transcriptional coactivator in mammalian
ells, the Gal4DB-Yki fusion protein exhibited potent
ranscriptional activation (Figure 5B). Strikingly, tran-
criptional activity of the Gal4DB-Yki fusion was abol-
shed when Hpo, Sav, and Wts plasmids were coex-
ressed (Figure 5B). This effect is specific to Yki since
ctivity of the full-length Gal4 (with its own activation
omain) was unaffected by the coexpression of Hpo,
av, and Wts (Figure 5B). These results suggest that
he Hpo pathway negatively regulates the coactivator
ctivity of Yki.
osage-Sensitive Genetic Interactions
etween yki and the Hpo Pathway
o further probe a functional link between yki and the
po pathway, we investigated their genetic interac-
ions. We have shown previously that while expression
f hpo or wts directly from the GMR promoter results
n viable flies with rough or slightly rough eyes, respec-
ively, cointroduction of GMR-hpo and GMR-wts into
he same animals results in 100% lethality at early pu-
al stage (Wu et al., 2003). Strikingly, such lethality was
ompletely rescued by coexpression of yki from a
MR-yki transgene (Figure 5C). Interestingly, this lethal-
ty was also completely rescued by coexpression of the
uman YAP gene (Figure 5C). In another line of experi-
ents, we took advantage of the complete pupal lethal-
ty caused by the overexpression of UAS-hpo driven
y the GMR-Gal4 driver (Figure 5D). Interestingly, this
ethality was also rescued by the coexpression of yki
100% rescue) or YAP (21% rescue) (Figure 5D). Taken
ogether, these genetic interactions further support our
odel that Yki acts antagonistically to Hpo, Sav, and
ts in a common signaling pathway. The ability of a
uman YAP transgene to rescue the lethality of flies
aused by Hpo pathway hyperactivation reveals a func-
ional conservation between Yki and YAP, suggesting
hat YAP might play a similar role in mammalian
rowth control.
Yki, Target of the Wts/Lats Tumor Suppressor
427Figure 4. yki Is Required for Tissue Growth and Transcriptional Regulation of diap1
For confocal images, single-channel and composite pictures are shown as indicated.
(A) Generation of yki knockout by gene targeting. The diagram at left shows organization of the endogenous yki locus, the targeting construct,
and the expected targeted allele. DNA probe used for Southern blotting is shown as a solid line, and the sizes (in kilobases) of expected
BamHI fragments are indicated. The right shows Southern blotting of BamHI-digested genomic DNA hybridized with the indicated probe.
DNA was extracted from wild-type flies (w1118) and three independent yki knockout lines recovered from gene targeting (as heterozygotes
over the CyO balancer). The size of the molecular weight marker is indicated to the right of the autoradiograph. While the endogenous yki
locus produces a 10.7 kb fragment, the targeted allele produces a 12.7 kb band.
(B and B#) Scanning electron micrographs (SEM) of wild-type flies showing a dorsal view of the head (B) and a side view of the compound
eye (B#). The genotype is y w ey-flp; FRT42D/FRT42D w+ l(2)c1-R11.
(C and C#) SEM of fly heads composed predominantly of cells lacking yki function. A dorsal view (C) and a side view (C#) are shown. The
genotype is y w ey-flp; FRT42D ykiB5/FRT42D w+ l(2)c1-R11.
(D–D$) Third instar wing disc containing yki mutant clones (induced by FLP/FRT at 40 hr AED) and stained with propidium iodide (PI).
Homozygous −/− clones, marked by the absence of GFP, were largely undetectable, with rare exceptions containing 1–3 cells (white arrow).
In contrast, the sibling +/+ twin spots, marked by the 2XGFP signal (darker green, yellow arrow), were readily observed.
(E–E$) Third instar eye disc containing yki mutant clones (marked by lack of GFP) and stained for the neuronal-specific Elav protein. Mutant
clones were induced at 60 hr AED to allow for more efficient recovery of yki mutant cells. Note the presence of Elav-positive cells in yki
mutant clones (arrow). Arrowhead marks the MF.
(F–F$) yki mutant clones (marked by lack of GFP) were generated in flies containing the diap1-lacZ reporter, and a third instar eye disc was
stained for lacZ (red) and the nuclear stain PI (blue). Note the cell-autonomous decrease in diap1-lacZ levels in yki mutant clones (white
arrow) and the smaller size of the yki mutant clone as compared to the twin spots (yellow arrow). Arrowhead marks the MF.Phosphorylation of Yki by Wts
Given the direct interaction between Yki and Wts (Fig-
ure 1) and that Wts encodes a protein kinase, we hy-
pothesized that Yki is regulated by the Hpo pathway
through Wts-mediated phosphorylation. To test this
possibility, we first examined phosphorylation of Yki bythe Hpo pathway using an S2 cell-based assay. As
shown in Figure 6A, coexpression of Wts and Yki re-
sulted in a small mobility retardation of Yki. Coexpres-
sion of Hpo-Sav with Yki also resulted in a mobility shift
of Yki, and coexpression of Hpo-Sav-Wts resulted in an
even greater mobility shift of Yki. The mobility shift of
Cell
428Figure 5. The Hpo Signaling Pathway Antagonizes the Transcriptional Coactivator Activity of Yki
(A) Schematic diagram of Gal4-related constructs used in the S2 cell transcription assay.
(B) Coactivator activity of Yki and its negative regulation by the Hpo pathway. S2 cells were transfected with the indicated plasmids along
with a Gal4-responsive luciferase reporter. Luciferase activities relative to those obtained with Gal4 DNA binding domain alone (Gal4DB) are
plotted. Error bars represent standard deviation from three independent transfections.
(C) Antagonistic, dosage-sensitive interactions between yki and hpo-wts. The percentage of flies surviving to adults is shown for the indicated
genotypes (>200 animals scored for each genotype). Note the complete lethality of GMR-hpo; GMR-wts animals, which was completely
reversed by GMR-yki, or expression of the human YAP gene under the GMR-Gal4 driver (GMR-Gal4; UAS-YAP).
(D) Genetic interactions between yki and hpo. The percentage of flies surviving to adults is shown for the indicated genotypes (>200 animals
scored for each genotype). The lethality of GMR-GAL4; UAS-hpo animals was completely and partially rescued by yki and YAP, respectively
(crosses done at 18°C).Yki induced by Hpo-Sav-Wts expression was abro- k
tgated by phosphatase treatment, demonstrating that
this shift is due to protein phosphorylation (Figure 6B). i
sIt is worth noting that the increasing phosphosphoryla-
tion of Yki induced by Wts, Hpo-Sav, and Hpo-Sav-Wts t
in the S2 cell assay (Figure 6A) correlates with the se-
verity of the overexpression phenotype caused by the l
Yrespective transgenes in vivo: expression of Wts by the
GMR promoter results in slightly rough eyes, expres- c
Wsion of Hpo-Sav results in strong rough eyes with re-
duced size, and expression of Hpo-Sav-Wts results in p
Hcomplete animal lethality (Tapon et al., 2002; Wu et al.,
2003). These results suggest that Yki phosphorylation p
eis a relevant output of the Hpo signaling pathway.
To determine whether Yki is a direct substrate of Wts, m
twe carried out in vitro kinase assays. When expressed
alone, Wts had little kinase activity on Yki (Figure 6C,
lane 1). When coexpressed with Hpo-Sav, however, Wts y
Tdisplayed specific kinase activity on Yki (Figure 6C,
lane 2) but not a control substrate (Figure 6C, lane 4). y
cMoreover, a kinase-dead mutation of Wts completely
abolished the in vitro kinase activity of Wts toward Yki s
H(Figure 6C, lane 3). These data confirm that Yki is ainase substrate of Wts. Furthermore, the observation
hat Hpo-Sav coexpression stimulates the kinase activ-
ty of Wts on Yki is consistent with our previous report
howing activation of Wts by Hpo-Sav as measured by
he phosphorylation status of Wts (Wu et al., 2003).
If Hpo-Sav activates Wts, which in turn phosphory-
ates Yki, one would predict that the mobility shift of
ki induced by transfected Hpo-Sav or Wts in our S2
ell assay (Figure 6A) might require the endogenous
ts or Hpo, respectively. Indeed, RNAi of wts com-
letely reversed the mobility shift of Yki induced by
po-Sav expression (Figure 6D), and RNAi of hpo com-
letely reversed the mobility shift of Yki induced by Wts
xpression (Figure 6E). These data further support our
odel that Yki is phosphorylated by Wts upon activa-
ion of the Hpo pathway.
ki Is Genetically Epistatic to hpo, sav, and wts
he genetic evidence presented so far suggests that
ki acts antagonistically to hpo, sav, and wts. Our bio-
hemical studies further refined this model and demon-
trate that Yki is phosphorylated and inactivated by the
po pathway via Wts-mediated phosphorylation. A pre-
Yki, Target of the Wts/Lats Tumor Suppressor
429Figure 6. Phosphorylation of Yki by Wts
(A) Lysates from S2 cells expressing various
epitope-tagged proteins were probed with
indicated antibodies. Increasingly phosphor-
ylated forms of Yki are indicated by small cir-
cles next to the protein bands and filled with
white, gray, and black colors.
(B) Phosphatase (CIP) treatment reversed
the mobility shift of Yki induced by Hpo-
Sav-Wts.
(C) Wts phosphorylates Yki in vitro. V5-
tagged Wts or kinase-dead WtsK743R was ex-
pressed alone or together with Hpo-Sav in
S2 cells, immunoprecipitated, and tested for
kinase activity against GST-Yki and GST-
Tsc1 (as a control substrate). The signal of
Yki phosphorylation by Wts is indicated by
arrowheads, and the arrow marks the ex-
pected migration position of GST-Tsc1 on
autoradiograph (top gel). The input kinase
and substrate are also shown (bottom two
gels). Note that our GST-Yki preparation con-
tains two Yki-related bands (arrowheads) as
well as a contaminating band (black dots,
see Experimental Procedures for details).
Note that only the Yki-related bands are
phosphorylated, and that Yki phosphoryla-
tion is only detected when Wts is coex-
pressed with Hpo-Sav (lane 2).
(D) S2 cells were transfected with the indi-
cated plasmids along with control or wts
dsRNA and probed with indicated antibod-
ies. Note suppression of the Yki mobility shift
by wts RNAi.
(E) S2 cells were transfected with the indi-
cated plasmids along with control or hpo
dsRNA and probed with indicated antibod-
ies. Note suppression of the Yki mobility shift
by hpo RNAi.diction of this model is that loss-of-function mutations
of yki should be genetically epistatic to those of hpo,
sav, or wts. To test this hypothesis, we generated
clones of cells that are doubly mutant for hpo-yki, sav-
yki, or wts-yki. While loss of hpo, sav, or wts results in
increased diap1 transcription and overgrowth (Wu et
al., 2003), hpo-yki, sav-yki, or wts-yki double mutant
clones displayed phenotypes indistinguishable from
those of yki mutant clones, including retarded growth,
decreased DIAP1 protein levels, and decreased diap1
transcription (Figure 7). These genetic observations fur-
ther strengthen our molecular model implicating Yki as
a target of Wts in the Hpo pathway.
Discussion
The mechanisms of how body and organ size are regu-
lated are just beginning to be understood (Conlon and
Raff, 1999; Hipfner and Cohen, 2004). Recent studies
in Drosophila have implicated a number of pathways in
the coordinate control of cell growth, proliferation, and
apoptosis, which ultimately regulate body and organ
size. The insulin/Tsc/TOR signaling network, for exam-
ple, plays a major role in coordinating organ growth
with environmental cues such as nutrients (Hafen,
2004; Pan et al., 2004). The Hpo signaling pathway, on
the other hand, might contribute to an intrinsic size“checkpoint” that normally stops growth when a given
organ reaches its characteristic size. Thus, molecular
elucidation of the Hpo signaling pathway should pro-
vide important insights into size-control mechanisms
in development.
Identification of Yki as a Direct Target of Wts/Lats
in the Hpo Pathway
Previous studies of the Wts/Lats tumor suppressor
have failed to identify any target of this kinase that
could account for its potent growth-regulatory activity.
Here, we provide genetic and biochemical evidence im-
plicating Yki, the Drosophila ortholog of the mammalian
coactivator protein YAP, as a direct, critical target of
Wts/Lats in the Hpo pathway (Figure 8). Yki associates
with and is phosphorylated by Wts. Moreover, Wts-
mediated phosphorylation of Yki is stimulated by up-
stream components of the Hpo pathway, and the extent
of Yki phosphorylation induced by Hpo pathway com-
ponents in vitro correlates with the severity of the over-
expression phenotype caused by the respective trans-
genes in vivo. Most importantly, overexpression of yki
phenocopies loss of hpo, sav, or wts, while loss of yki
results in the opposite phenotype, and our epistasis
analyses unambiguously placed yki downstream of
hpo, sav, and wts. Taken together, these results provide
compelling evidence that Yki is a critical target of Wts/
Cell
430Figure 7. yki Is Genetically Epistatic to hpo,
sav, and wts
In all panels, mutant clones were generated
at 40 hr AED and marked by the lack of GFP.
(A)–(D$) show eye imaginal discs, and (E)–(G)
show wing imaginal discs. Single-channel
and composite confocal images are shown
as indicated.
(A–D$) Third instar eye disc containing yki
(A–A$), hpo-yki (B–B$), sav-yki (C–C$), and
wts-yki (D–D$) mutant clones in the pres-
ence of thj5c8 and stained with antibodies
against DIAP1 (blue) and lacZ (red). Note that
all the mutant clones show a cell-autono-
mous decrease of DIAP1 and diap1-lacZ, as
well as growth disadvantage as compared to
the twin spots (marked by 2XGFP signal,
darker green).
(E–G) Third instar wing discs containing
double mutant clones of hpo-yki (E), sav-yki
(F), and wts-yki (G). Note the presence of +/+
twin spots, marked by 2XGFP signal (yellow
arrow), and a general absence of homozy-
gous mutant cells (marked by the absence
of GFP). This phenotype is similar to yki wing
clones generated at 40 hr AED (see Figures
4D–4D$).Lats in the Hpo pathway. We further speculate that the t
drelationship between Yki and Hpo signaling is likely
conserved during evolution since overexpression of c
mmammalian YAP was able to rescue the lethality associ-
ated with hyperactivation of the Hpo pathway in Dro- e
ssophila. The functional conservation between Yki and
YAP further suggests that YAP might function as an on- t
Ncogene in mammals.
To our knowledge, Yki is the first substrate identified h
sfor NDR family kinases, which include, besides Wts/
Lats, Cbk1, Dbf2, and Dbf20 in budding yeast, Sid2 and
Orb6 in fission yeast, Cot-1 in Neurospora, Sax-1 in R
bC. elegans, Trc in Drosophila, and NDR1 and NDR2 in
mammals (reviewed by Tamaskovic et al., 2003). The I
pNDR family kinases are involved in diverse events in
cell-cycle and cell morphogenesis, such as maintaining S
mcell polarity (Cbk1 and Orb6), coordinating CDK inacti-
vation and cytokinesis (Dbf2, Dbf20, and Sid2), and t
tneuronal morphogenesis (Sax-1). Despite their diverse
cellular functions, all NDR family kinases share similar a
Wstructural features, such as the insertion of 30–60
amino acids between kinase subdomains VII and VIII, vhe presence of conserved activation loop and hy-
rophobic motif, and the presence of N-terminal non-
atalytic domain (Tamaskovic et al., 2003). These com-
on features suggest that NDR family kinases may
mploy similar mechanisms to interact with their sub-
trates and regulators. Along this line, we suggest that
he approach described in this study, which uses the
-terminal noncatalytic domain of Wts as yeast two-
ybrid bait, might provide a general method to discover
ubstrates for other NDR family kinases.
egulation of NDR Family Kinases
y Ste20-like Kinases
n our previous studies of the Hpo pathway, we pro-
osed a model whereby Hpo, somehow facilitated by
av, phosphorylates Wts (Wu et al., 2003). While our
odel implied that phosphorylation of Wts leads to ac-
ivation of its kinase activity, we were previously unable
o directly test this due to the lack of an appropriate
ssay that measures pathway activity downstream of
ts. The identification of Yki as a Wts substrate pro-
ides a new tool to evaluate our earlier model. Consis-
Yki, Target of the Wts/Lats Tumor Suppressor
431Figure 8. A Model of the Hpo Signaling Pathway in the Control of
Organ Growth
An unknown signal controls Hpo, which in turn phosphorylates and
activates Wts. The activation of Wts by Hpo is potentiated by Sav
and Mats, which have been shown to associate with Hpo and Wts,
respectively. The exact mechanism of this potentiation remains to
be determined. The activated Wts kinase phosphorylates and inac-
tivates the transcriptional coactivator Yki, which normally partners
with an unknown DNA binding transcription factor (X) to activate
gene transcription. Transcriptional targets of the Yki-X transcription
complex include the cell-death inhibitor diap1 and possibly cell-
cycle regulators such as cyclin E. There also likely exist target(s) of
the Yki-X complex that regulate cell growth since cell growth must
be proportionally stimulated to sustain the increased proliferation
of hpo, sav, wts, and mats mutant cells. It remains to be determined
how the activity of the Hpo signaling pathway is regulated during
the growth of imaginal discs.tent with our previous model implicating Hpo as an acti-
vating kinase of Wts, we show that in S2 cells, the
phosphorylation of Yki induced by transfected Wts is
dependent on the endogenous Hpo protein (Figure 6E).
Furthermore, the in vitro kinase activity of Wts toward
Yki is strongly stimulated when Wts is coexpressed
with Hpo-Sav. We suggest that such a relationship be-
tween Hpo and Wts is likely conserved during evo-
lution. Indeed, a recent study has demonstrated the
activation of the mammalian Lats1 kinase by the mam-
malian Hpo homologs Mst1/Mst2 (Chan et al., 2005).
It is worth noting that several Ste20-like kinases have
been implicated in the activation of NDR kinases. Such
examples include the activation of Wts by Hpo (Wu et
al., 2003; Chan et al., 2005), the activation of Dbf2 by
Cdc15 (Mah et al., 2001), the regulation of Orb6 by Pak1
(Verde et al., 1998), and the regulation of Sid2 by Sid1
(Guertin et al., 2000). Thus, activation by Ste20-like ki-
nases might represent a general mechanism for regu-lating NDR kinases. In retrospect, the difficulties in
identifying substrates for NDR kinases might be due to
their substrate specificity in conjunction with a require-
ment for activation by upstream kinases. Another
emerging feature of the NDR kinases concerns their
regulation by the Mob family of small regulatory pro-
teins, which have been found to associate with multiple
NDR family kinases, such as Dbf2, Orb6, Sid2, Cbk1,
NDR1, and NDR2 (Tamaskovic et al., 2003). In Drosoph-
ila, Mats, a Mob family protein, has recently been iden-
tified as a tumor suppressor gene that likely regulates
Wts in the Hpo signaling pathway (Lai et al., 2005).
Thus, regulation by Mob family proteins likely repre-
sents an important and shared feature of modulating
NDR family kinases.
Transcriptional Regulation of diap1 by the Hpo
Signaling Pathway
Previous studies of Hpo signaling suggested two con-
trasting models on how this pathway regulates the cell-
death regulator DIAP1. Using a diap1-lacZ reporter to
follow diap1 transcription, we have observed elevated
diap1 transcription in mutant clones of hpo, sav, or wts
that closely matches the increase in DIAP1 protein
levels. Based on these results, we proposed that the
Hpo pathway negatively regulates diap1 at the level of
transcription (Wu et al., 2003). However, an alternative
model suggested that Hpo regulates DIAP1 posttran-
scriptionally by directly phosphorylating DIAP1, thus
promoting its degradation (Tapon et al., 2002; Harvey
et al., 2003; Pantalacci et al., 2003). This model was
largely based on two lines of evidence, including in situ
hybridization showing unchanged diap1 mRNA level in
mutant clones and the ability of Hpo to phosphorylate
DIAP1 in vitro. We note, however, that in situ hybridiza-
tion used in the latter studies did not involve the mark-
ing of mutant clones and thus may be less definitive
than the diap1-lacZ reporter. A major drawback of the
posttranscriptional model is that it cannot easily ac-
count for the involvement of Wts in the Hpo pathway.
A direct link between Hpo and DIAP1 inevitably implies
Wts as acting upstream or in parallel with Hpo, which
is contradictory to other studies of the NDR kinases
that generally place them downstream of the Ste20-like
kinases (Wu et al., 2003; Chan et al., 2005; Mah et al.,
2001; Verde et al., 1998; Guertin et al., 2000).
If the Hpo signaling pathway regulates diap1 via a
transcriptional mechanism, then there should exist
transcriptional regulator(s) that control diap1 transcrip-
tion and whose activity may be regulated by the Hpo
signaling pathway. Furthermore, such transcriptional
regulator(s) must account for the mutant phenotypes
resulting from deregulation of the Hpo pathway, such
as changes in diap1 transcription and overgrowth. Our
current study demonstrates that Yki represents such a
regulator, thus further supporting our previous model
implicating the Hpo pathway in regulating diap1 tran-
scription.
Understanding the molecular mechanisms by which
the Hpo pathway regulates diap1 transcription will pro-
vide important insights into the developmental coordi-
nation of tissue growth and apoptosis. Like other co-
activators, Yki presumably functions by interacting with
Cell
432wDNA binding transcription factors. YAP, the mammalian
Ihomolog of Yki, is known to function as coactivator for
pa number of transcription factors, such as the p53 fam-
A
ily member p73 (Strano et al., 2001), the Runt family a
member PEBP2α (Yagi et al., 1999), and the four TEAD/ 5
uTEF transcription factors (Vassilev et al., 2001). This in-
2teraction is generally mediated by WW domains of YAP
oand PPxY motifs of the cognate transcription factors.
pAt present, it is unclear whether any of the reported
D
mammalian proteins represents the physiological part- c
ner for YAP. Along this line, it is worth noting that while F
cthe reported ability of YAP to transactivate p73 in cul-
tured mammalian cells is more suggestive of a tumor
dsuppressor function for YAP (Basu et al., 2003), our
tstudies clearly implicate Yki and YAP as potential onco-
p
genes. One interesting possibility is that the reported b
coupling of mammalian YAP to p73 might represent a
fail-safe mechanism to limit the oncogenic potential of Y
YAP in much the same way as cell death is obligatorily Y
tlinked to oncogene activation (Lowe et al., 2004).
tAn important direction in the future is to identify the
tDNA binding transcription factor (denoted as “X” in
(
Figure 8) that partners with Yki to regulate gene tran- a
scription; identifying the factor should provide critical c
insights into how Yki (and likely YAP as well) could c
Gfunction as a potent oncogene. This effort should be
gfacilitated by the dissection of the diap1 promoter and
fthe identification of a minimal Hpo-responsive element
r
that confers transcriptional regulation of diap1 by the b
Hpo pathway. With such a DNA element, one should be m
able to identify the DNA binding transcription factor
tthat partners with Yki to regulate the transcription of
tdiap1 and other Hpo-pathway-responsive genes.
h
r
A Conserved Role for the Hpo Pathway in t
mMammalian Growth Control and Tumorigenesis?
mMany components of the Hpo pathway are conserved
uthroughout evolution, suggesting that this emerging
dpathway might play a similar role in mammals. Indeed, t
previous studies have shown that human homologs of T
wts, hpo, and mats could rescue the respective Dro-
sophila mutants (Tao et al., 1999; Wu et al., 2003; Lai et D
al., 2005). Moreover, mice lacking a wts homolog are A
lprone to tumor formation (St John et al., 1999), and the
Ghuman orthologs of sav and mats are mutated in sev-
peral cancer cell lines (Tapon et al., 2002; Lai et al., 2005).
c
Such conservation is further extended in the current a
study, showing that Yki and YAP have similar biological c
activity when assayed in Drosophila. These results sug-
Fgest that the Hpo signaling pathway might play a con-
gserved role in mammalian growth control. Furthermore,
iinactivation of growth suppressors of the Hpo pathway,
such as Hpo, Sav, Wts, and Mats, and hyperactivation
of growth promoters of the pathway, such as YAP, are
likely to contribute to mammalian tumorigenesis.
U
Experimental Procedures
UGene Targeting and Rescue of yki
The ends-out gene targeting strategy (Gong and Golic, 2003) in-
volves cloning DNA segments flanking the target locus into a spe- S
Hcially designed vector containing a whs marker gene between the
homologous DNA segments, as well as features that allow the gen- D
teration of a linear DNA template for homologous recombinationith the target locus following the action of FLP recombinase and
-SceI endonuclease. To construct yki knockout construct, two
airs of oligos, 5#-AGCAGGCGCGCCAATGTATACATCTGTATTAG
CC-3# and 5#-AGCAGGCGCGCCCTTACAAAACTTTTGCCACTG-3#,
nd 5#-AGCAGCGGCCGCGGGGTGTTAGTAGCTTCAGGTT-3# and
#-AGCAGCGGCCGCATCTTAGCGATTAGGCACGCGCAC-3#, were
sed to amplify DNA fragments of w4 kb from the BAC clone
7M17. These fragments were cloned into the AscI and NotI sites
f pW25, respectively. This targeting construct is expected to re-
lace all the coding sequence of yki (19573700–19575921 of the
rosophila genome sequence) with whs. Flies carrying the targeting
onstruct on the 3rd chromosome were crossed to flies carrying the
LP and I-SceI enzymes, and the progeny were screened for pre-
ise gene targeting as described (Gong and Golic, 2003).
yki rescue construct was made by cloning a full-length yki cDNA
ownstream from the α-tubulin promoter. Multiple insertions of the
ub-yki construct were tested for their ability to rescue three inde-
endently derived yki knockout alleles. All transgene/mutant com-
inations resulted in complete rescue.
east Two-Hybrid Screen
east two-hybrid was carried out using Stratagene’s CytoTrap sys-
em, which is based on the ability of human Sos to complement a
emperature-sensitive cdc25 allele (cdc25H) in yeast when Sos is
argeted to the plasma membrane through bait-prey interactions
Aronheim et al., 1997). In this system, the bait protein is expressed
s a fusion protein with human Sos. The prey library contains cDNA
lones fused with a myristylation signal that targets proteins to the
ell membrane. Expression of the prey is further controlled by the
AL1 promoter, which is induced on galactose but repressed on
lucose medium. When the bait and the cDNA library are cotrans-
ormed into the cdc25H strain, the only cells capable of growing at
estrictive temperature on galactose medium are those that have
een rescued by bait-prey interactions that recruit Sos to the cell
embrane.
The three yki clones recovered from the yeast screen differ in
heir N termini but are otherwise identical, all including the termina-
ion codon and polyA. The Berkeley Drosophila Genome Project
as sequenced a cDNA (LD21311) from the yki locus. LD21311 rep-
esents a differentially spliced form of yki and differs from our yeast
wo-hybrid positives in that the former contains only one WW do-
ain. Compared to the two-WW form, the one-WW form of Yki has
uch reduced activity in overexpression and rescue assays (J.H.,
npublished data). To construct a full-length yki cDNA with two WW
omains, a BamHI-XhoI fragment of LD12311 was replaced with
he corresponding fragment from the yeast two-hybrid positives.
he resulting yki cDNA was used in all subsequent studies.
rosophila Strains
ll crosses were done at 25°C unless otherwise indicated. The fol-
owing flies have been described: GMR-Hpo (Wu et al., 2003),
MR-Wts (Tapon et al., 2002), hpo42-47 (Wu et al., 2003), sav3 (Ta-
on et al., 2002), wtsX1 (Xu et al., 1995), thj5c8 (Hay et al., 1995),
ycE-lacZ (Jones et al., 2000). yki cDNA was cloned into pUAST
nd pGMR, and a human YAP cDNA (IMAGE clone 5747370) was
loned into pUAST to generate UAS-YAP.
FLP/FRT was used to generate mutant clones in imaginal discs.
or double mutant clones of hpo, sav, or wts with yki, the following
enotypes were used. Note that a tub-yki insertion on 3R was used
n generating sav yki and wts yki double mutant clones.
hpo yki double mutant clones:
y w hsp-flp; FRT42D hpo42-47 ykiB5/FRT42D Ubi-GFP
sav yki double mutant clones:
y w hsp-flp; FRT42D ykiB5/FRT42D ykiB5; FRT82B sav3/FRT82B
bi-GFP P[tub-yki]
wts yki double mutant clones:
y w hsp-flp; FRT42D ykiB5/FRT42D ykiB5; FRT82B wtsX1/FRT82B
bi-GFP P[tub-yki]
2 Cell Assays
A-Yki was constructed by adding a C-terminal HA tag (YPYDVP-
YA) using the pAc5.1/V5-HisB vector (Invitrogen). N-terminal V5-
agged Wts was constructed in the same vector by adding a V5
Yki, Target of the Wts/Lats Tumor Suppressor
433tag (GKPIPNPLLGLDST) between the first and second codons of
Wts. Point mutations of Yki and Wts were introduced using the
QuikChange mutagenesis kit (Stratagene). Myc-tagged Hpo and
Flag-tagged Sav have been described (Wu et al., 2003). Full length
Yki was cloned into pGEX4T-1 to express a GST-Yki fusion protein.
Our GST-Yki preparation contained two Yki-related bands, with the
upper band migrating at the expected molecular weight. It also
contained a contaminating band (Figure 6C). The Yki-related
bands, but not the contaminating band, were diminished by throm-
bin, which cleaves the GST-Yki fusion at the junction of GST and
Yki (data not shown). GST-Tsc1 fusion has been described (Wu et
al., 2003). Transfection, immunoprecipitation, and in vitro kinase as-
say were carried out as described (Wu et al., 2003).
An in-frame fusion of the DNA binding domain (DB) of Gal4 and
full-length Yki was constructed in pActGal4(1-147)SK (a gift of Al-
bert Courey). The resulting plasmid, pActGal4DB-Yki, was trans-
fected in triplicates with G5-37tkluc, a Gal4-responsive luciferase
reporter (a gift of Albert Courey), with or without plasmids express-
ing Hpo, Sav, and Wts. Luciferase assay was carried out using Lu-
ciferase Assay System (Promega) and a FLUOstar luminometer
(BMG LabTechnologies).
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